Covered recipient · General Payments record
JULIE LOFTUS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,507.44
- Reported across 78 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $720.75 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $247.96 | 11 |
| Astellas Pharma US Inc | $171.87 | 4 |
| Novo Nordisk AS | $145.16 | 4 |
| PFIZER INC. | $55.84 | 3 |
| Acerta Pharma LLC | $43.03 | 3 |
| DEXCOM, INC. | $21.60 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.85 | 1 |
| Exact Sciences Corporation | $17.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.61 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107550362 | CMS |
| ABBVIE INC. | $13.01 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107550364 | CMS |
| ABBVIE INC. | $23.71 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107550366 | CMS |
| ABBVIE INC. | $9.28 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107550368 | CMS |
| ABBVIE INC. | $8.05 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107550370 | CMS |
| ABBVIE INC. | $119.70 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107550372 | CMS |
| ABBVIE INC. | $6.96 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107550374 | CMS |
| ABBVIE INC. | $11.77 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107550376 | CMS |
| ABBVIE INC. | $7.00 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107550378 | CMS |
| ABBVIE INC. | $15.51 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107550380 | CMS |
| ABBVIE INC. | $5.36 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107550382 | CMS |
| Astellas Pharma US Inc | $17.78 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139462094 | CMS |
| Astellas Pharma US Inc | $9.11 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139462124 | CMS |
| Astellas Pharma US Inc | $124.97 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139524724 | CMS |
| Astellas Pharma US Inc | $20.01 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139514361 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.91 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104337112 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.12 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104462862 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.00 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105356563 | CMS |
| Dexcom, Inc. | $21.60 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153368623 | CMS |
| Exact Sciences Corporation | $17.44 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114761086 | CMS |
| Novo Nordisk Inc | $18.69 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100461606 | CMS |
| Novo Nordisk Inc | $121.74 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100456988 | CMS |
| Novo Nordisk Inc | $2.21 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100305523 | CMS |
| Novo Nordisk Inc | $2.52 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100284940 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.85 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119124114 | CMS |
| PFIZER INC. | $17.33 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132005706 | CMS |
| PFIZER INC. | $18.33 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131913257 | CMS |
| PFIZER INC. | $20.18 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132093090 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.